These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19351523)

  • 1. hERG1 channel activators: a new anti-arrhythmic principle.
    Grunnet M; Hansen RS; Olesen SP
    Prog Biophys Mol Biol; 2008; 98(2-3):347-62. PubMed ID: 19351523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
    Grunnet M
    Acta Physiol (Oxf); 2010 Feb; 198 Suppl 676():1-48. PubMed ID: 20132149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HERG K+ channel, the target of anti-arrhythmias drugs].
    Guan FY; Yang SJ
    Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HERG1 channel agonists and cardiac arrhythmia.
    Sanguinetti MC
    Curr Opin Pharmacol; 2014 Apr; 15():22-7. PubMed ID: 24721650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
    Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
    Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants.
    Hassel D; Scholz EP; Trano N; Friedrich O; Just S; Meder B; Weiss DL; Zitron E; Marquart S; Vogel B; Karle CA; Seemann G; Fishman MC; Katus HA; Rottbauer W
    Circulation; 2008 Feb; 117(7):866-75. PubMed ID: 18250272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of potassium currents in cardiac arrhythmias.
    Ravens U; Cerbai E
    Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
    Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ
    Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643.
    Grunnet M; Abbruzzese J; Sachse FB; Sanguinetti MC
    Mol Pharmacol; 2011 Jan; 79(1):1-9. PubMed ID: 20876384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activation of rapid delayed rectifier potassium current suppresses bradycardia-induced triggered activity in the isolated guinea pig heart.
    Hansen RS; Olesen SP; Grunnet M
    J Pharmacol Exp Ther; 2007 Jun; 321(3):996-1002. PubMed ID: 17325228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy.
    Billman GE
    Pharmacol Ther; 2008 Oct; 120(1):54-70. PubMed ID: 18708091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS; Olesen SP; Rønn LC; Grunnet M
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):35-41. PubMed ID: 18594476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac ion channels and mechanisms for protection against atrial fibrillation.
    Grunnet M; Bentzen BH; Sørensen US; Diness JG
    Rev Physiol Biochem Pharmacol; 2012; 162():1-58. PubMed ID: 21987061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators.
    Guo J; Durdagi S; Changalov M; Perissinotti LL; Hargreaves JM; Back TG; Noskov SY; Duff HJ
    PLoS One; 2014; 9(9):e105553. PubMed ID: 25191697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced ion currents and the endothelin pathway as targets for anti-arrhythmic agents.
    Dai DZ; Dai Y
    Curr Opin Investig Drugs; 2008 Sep; 9(9):1001-8. PubMed ID: 18729007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico risk assessment for drug-induction of cardiac arrhythmia.
    Suzuki S; Murakami S; Tsujimae K; Findlay I; Kurachi Y
    Prog Biophys Mol Biol; 2008 Sep; 98(1):52-60. PubMed ID: 18635251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction.
    Wood DM; Dargan PI; Hoffman RS
    Clin Toxicol (Phila); 2009 Jan; 47(1):14-23. PubMed ID: 18815938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use-dependent modulation of myocardial conduction by a new class of HERG agonists: deal breaker or cherry on top?
    Akar FG
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):930-2. PubMed ID: 20367661
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes.
    Meadows LS; Isom LL
    Cardiovasc Res; 2005 Aug; 67(3):448-58. PubMed ID: 15919069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.